Analyst Ranking
Top 11%
#462 out of 4544 analysts
Average Return
Win Rate
50%42 out of 84
Risk vs Reward

Kyle Rose's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Inmode LtdINMD
2020-10-20 -
Strong Buy
Inmode LtdINMD
2020-05-06 -
Strong Buy
Dexcom IncDXCM
2017-09-27 -
Strong Buy
Conformis IncCFMS
2018-10-31 -
Strong Buy
Dexcom IncDXCM
2018-02-27 -
Strong Buy

Kyle Rose Analyst Color

Get additional color on Kyle Rose's coverage of popular stocks

Kyle Rose's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Stryker CorpSYK
10Strong Buy$360.00+5.25%Upgrades
2 months ago
Globus Medical IncGMED
5Strong Buy$71.00+37.41%Maintains
4 months ago
Enovis CorpENOV
3Strong Buy$71.00+21.26%Maintains
4 months ago
Inmode LtdINMD
6 months ago
Beauty Health CoSKIN
4Strong Buy$10.00+173.22%Assumes
8 months ago
Alphatec Holdings IncATEC
4Strong Buy$22.00+65.41%Maintains
8 months ago
Dexcom IncDXCM
17Strong Buy$150.00+10.18%Maintains
9 months ago
Vicarious Surgical IncRBOT
3Strong Buy$9.00+2,775.40%Maintains
10 months ago
Si Bone IncSIBN
3Strong Buy$27.00+80.36%Maintains
a year ago
Tela Bio IncTELA
1Strong Buy$15.00N/AReiterates
a year ago
Axogen IncAXGN
3Strong Buy$15.00N/AReiterates
a year ago
Intercontinental Exchange IncICE
a year ago
Koru Medical Systems IncKRMD
3Strong Buy$4.00N/AUpgrades
a year ago
Bioventus IncBVS
a year ago
Insulet CorpPODD
4Strong Buy$290.00N/AMaintains
2 years ago
Sientra IncSIENQ
8Strong Buy$80.00N/AMaintains
2 years ago
Paragon 28 IncFNA
2Strong Buy$23.00N/AMaintains
2 years ago
Zimmer Biomet Holdings IncZBH
2 years ago
Intersect Ent IncXENT
3 years ago
Misonix IncMSON
3 years ago
Smith & Nephew PLCSNN
2Strong Buy$55.00N/AMaintains
3 years ago
Nuvasive IncNUVA
3 years ago
Seaspine Holdings CorpSPNE
1Strong Buy$25.00N/AInitiates Coverage On
4 years ago
Conformis IncCFMS
4Strong Buy$62.50N/AMaintains
5 years ago
Entellus Medical IncENTL
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.